George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.00
Bid: 155.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.452%)
Open: 160.00
High: 160.00
Low: 160.00
Prev. Close: 160.00
TIDE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant mpro5 Contract Win in the Netherlands

11 Jul 2017 07:00

RNS Number : 6510K
Crimson Tide PLC
11 July 2017
 

CRIMSON TIDE PLC

("Crimson Tide" or "the Company")

SIGNIFICANT MPRO5 SUBSCRIPTION CONTRACT WIN IN THE NETHERLANDS

 

Crimson Tide (TIDE), the AIM-quoted provider of mpro5 - Smart Mobile Working, has secured a long term contract in The Netherlands with one of the world's largest facilities management companies.

The contract is worth a minimum of €200,000 with the potential to rise to a maximum of over €1m and is for a 48 month period

The client will use mpro5 for mobile scheduling, reporting and auditing of workflow and activities. Users of mpro5's enterprise mobile solutions pay a monthly subscription for software, cloud infrastructure, installation and all services required by their out-of-office teams. This makes for easy initial adoption, often followed by wider internal take-up as the performance benefits are established.

Barrie Whipp, Executive Chairman, commented: "We have been making a number of strategic growth investments internationally and this contract represents an excellent foundation for our expansion in Northern Europe. mpro5 is well positioned for organisations that have larger geographic footprints which, with our Microsoft Azure Cloud infrastructure, we are able to support."

For further information about the Company, please see www.crimsontide.co.uk, for specific information about mpro5 please visit the new http://www.mpro5.com

 

Contacts:

Crimson Tide plc, Barrie Whipp - 01892 542 444

WH Ireland Limited, James Joyce / James Bavister - 020 7220 1666

 

Notes to editors Founded in 1996 and quoted on AIM since 2006, Crimson Tide plc is the provider of mpro5 - Smart Mobile Working. mpro5 is delivered on smartphones, tablets and PDAs, and enables companies to transform their businesses and strengthen their workforces. Crimson Tide offers a global service, working with some of the world's leading companies, tailoring mpro5 to suit customer needs. Developed over 10 years by its world-class team, mpro5 is the smart choice for organisations large and small that want to improve productivity and save money. mpro5 is a platform-agnostic mobility suite fully hosted on Microsoft Azure, so customers are quickly up and running and the service is scalable and robust. It is provided on subscription, so clients can immediately see a return on their investment. mpro5 not only helps people improve their day-to-day working methods while saving employers money, it also saves lives, by enabling haemophilia patients to verify the safety of their medication before use. mpro5 clients come from a diverse range of industries allowing the Company to listen, share and find the best solution for all mobility needs.

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTDBLFFDDFLBBF
Date   Source Headline
4th Oct 20184:47 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSContract Wins and Recruitment
5th Jul 20188:38 amRNSmpro5 healthcare update
2nd Jul 201811:21 amRNSResult of AGM
7th Jun 20188:28 amRNSFinal Results and Notice of AGM
24th Apr 20187:00 amRNSChange of Adviser
13th Apr 20187:00 amRNSPreliminary Results to 31 December 2017
28th Mar 20187:00 amRNSAppointment of new CEO
27th Feb 20187:00 amRNSTrading Statement
19th Dec 20173:44 pmRNSDirector/PDMR Shareholding
15th Dec 201711:30 amRNSExercise of Options
8th Dec 20173:37 pmRNSResult of GM
23rd Nov 20177:00 amRNSNotice of GM
24th Oct 20177:00 amRNSSeries of contract wins for mpro5
17th Oct 20177:00 amRNSDirectorate Change
7th Sep 20177:00 amRNSInterim Results
11th Jul 20177:00 amRNSSignificant mpro5 Contract Win in the Netherlands
29th Jun 20175:47 pmRNSResult of AGM
6th Jun 20172:00 pmRNSFinal Results and Notice of AGM
30th May 20177:00 amRNSInternational Expansion Update
30th Mar 20177:00 amRNSPreliminary Results
2nd Feb 20177:00 amRNSUpdate on International Expansion
14th Dec 20167:00 amRNSTrading Update and Contract Rollout
18th Nov 20169:45 amRNSDirector/PDMR Shareholding
13th Oct 20167:00 amRNSSignificant long term contract win
12th Oct 20167:00 amRNSLong Term Contract with NCHCD
22nd Sep 20167:00 amRNSInterim Results
18th Jul 20167:00 amRNSCrimson Tide selected by large UK retailer
14th Jul 20167:00 amRNSPharmaceutical Verification Pilot
29th Jun 20168:31 amRNSResult of AGM
14th Jun 20167:00 amRNSMpro5 Contract Win
3rd Jun 20163:47 pmRNSFinal Results and Notice of AGM
20th May 20163:26 pmRNSExercise of Options
20th Apr 20167:00 amRNSPreliminary Results
25th Feb 20167:00 amRNSTrading Update
24th Feb 20163:34 pmRNSResult of Court Hearing
26th Jan 20162:37 pmRNSResult of General Meeting
30th Dec 20157:00 amRNSProposed Reconstruction of Capital
4th Dec 20157:00 amRNSUpdate on Significant Contract Win
7th Oct 20155:58 pmRNSHolding(s) in Company
1st Oct 20152:45 pmRNSDirector's Dealing
30th Sep 20157:00 amRNSInterim Results
17th Sep 20157:00 amRNSSignificant contract win
1st Jul 20157:00 amRNSResult of AGM
8th Jun 20157:00 amRNSFinal Results and Notice of AGM
4th Jun 20157:00 amRNSSignificant Contract Win
14th Apr 20157:00 amRNSContracts Update
2nd Apr 20157:00 amRNSPreliminary Results
20th Mar 201510:03 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.